Hemiablative focal brachytherapy pilot study

January 4, 2016

 

Whole gland LDR brachytherapy has been a well established modality of treating low risk prostate cancer. Treatment in a focal manner has the advantages of reduced toxicity to surrounding organs. The aim of this study is to determine the utility of focal LDR brachytherapy in form of hemiablative treatment for localized prostate cancer demonstrating the feasibility of the delivery of the prescription dose to the half of the prostate in terms of meeting standard dosimetric parameters while respecting same or lower tolerance doses of adjacent normal organs.

 

Read more here

Please reload

Recent Posts
Please reload

Archive
Please reload

Search By Tags
Please reload

Follow Us
  • LinkedIn Social Icon
  • Facebook Basic Square
  • Twitter Basic Square

Registered Address: The Coach House, Grenville Court, Britwell Road, Burnham, SL1 8DF

Company Registration No: 08252168

  • Black Facebook Icon
  • Black Twitter Icon
  • Black LinkedIn Icon
  • Black YouTube Icon